nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiamine—SLC22A5—Dactinomycin—skin cancer	0.579	1	CbGbCtD
Thiamine—Induration—Imiquimod—skin cancer	0.0261	0.0987	CcSEcCtD
Thiamine—SLC19A2—nipple—skin cancer	0.025	0.159	CbGeAlD
Thiamine—Induration—Bleomycin—skin cancer	0.0185	0.0701	CcSEcCtD
Thiamine—Feeling hot—Imiquimod—skin cancer	0.0149	0.0563	CcSEcCtD
Thiamine—SLC19A2—mammalian vulva—skin cancer	0.0146	0.0929	CbGeAlD
Thiamine—TPK1—female reproductive system—skin cancer	0.0141	0.09	CbGeAlD
Thiamine—Tenderness—Imiquimod—skin cancer	0.0134	0.0506	CcSEcCtD
Thiamine—SLC19A2—female reproductive system—skin cancer	0.0125	0.0796	CbGeAlD
Thiamine—TPK1—head—skin cancer	0.0118	0.0752	CbGeAlD
Thiamine—CYP4B1—mammalian vulva—skin cancer	0.0116	0.0742	CbGeAlD
Thiamine—SLC19A2—head—skin cancer	0.0104	0.0665	CbGeAlD
Thiamine—Pulmonary oedema—Imiquimod—skin cancer	0.0104	0.0393	CcSEcCtD
Thiamine—CYP4B1—female reproductive system—skin cancer	0.00997	0.0636	CbGeAlD
Thiamine—Tenderness—Bleomycin—skin cancer	0.00951	0.036	CcSEcCtD
Thiamine—CYP4B1—head—skin cancer	0.00833	0.0531	CbGeAlD
Thiamine—TPK1—lymph node—skin cancer	0.00826	0.0526	CbGeAlD
Thiamine—Tenderness—Fluorouracil—skin cancer	0.00739	0.0279	CcSEcCtD
Thiamine—SLC19A2—lymph node—skin cancer	0.0073	0.0466	CbGeAlD
Thiamine—Haemoglobin—Imiquimod—skin cancer	0.00589	0.0223	CcSEcCtD
Thiamine—Haemorrhage—Imiquimod—skin cancer	0.00586	0.0222	CcSEcCtD
Thiamine—CYP4B1—lymph node—skin cancer	0.00583	0.0372	CbGeAlD
Thiamine—Asthenia—Vismodegib—skin cancer	0.00567	0.0215	CcSEcCtD
Thiamine—SLC22A5—nipple—skin cancer	0.00567	0.0361	CbGeAlD
Thiamine—Pruritus—Vismodegib—skin cancer	0.00559	0.0212	CcSEcCtD
Thiamine—Anaphylactic shock—Vemurafenib—skin cancer	0.00488	0.0185	CcSEcCtD
Thiamine—Nausea—Vismodegib—skin cancer	0.0047	0.0178	CcSEcCtD
Thiamine—Agitation—Imiquimod—skin cancer	0.00469	0.0177	CcSEcCtD
Thiamine—Angioedema—Imiquimod—skin cancer	0.00466	0.0176	CcSEcCtD
Thiamine—Haemoglobin—Bleomycin—skin cancer	0.00419	0.0158	CcSEcCtD
Thiamine—Haemorrhage—Bleomycin—skin cancer	0.00416	0.0158	CcSEcCtD
Thiamine—Pulmonary oedema—Docetaxel—skin cancer	0.00414	0.0157	CcSEcCtD
Thiamine—Shock—Imiquimod—skin cancer	0.0041	0.0155	CcSEcCtD
Thiamine—Hyperhidrosis—Imiquimod—skin cancer	0.00403	0.0152	CcSEcCtD
Thiamine—SLC22A5—skin of body—skin cancer	0.00363	0.0231	CbGeAlD
Thiamine—Hypersensitivity—Vemurafenib—skin cancer	0.0036	0.0136	CcSEcCtD
Thiamine—Haemoglobin—Temozolomide—skin cancer	0.00353	0.0134	CcSEcCtD
Thiamine—Haemorrhage—Temozolomide—skin cancer	0.00351	0.0133	CcSEcCtD
Thiamine—Asthenia—Vemurafenib—skin cancer	0.0035	0.0133	CcSEcCtD
Thiamine—Pruritus—Vemurafenib—skin cancer	0.00346	0.0131	CcSEcCtD
Thiamine—SLC22A1—head—skin cancer	0.00341	0.0217	CbGeAlD
Thiamine—Urticaria—Imiquimod—skin cancer	0.00331	0.0125	CcSEcCtD
Thiamine—Haemoglobin—Fluorouracil—skin cancer	0.00325	0.0123	CcSEcCtD
Thiamine—Haemorrhage—Fluorouracil—skin cancer	0.00324	0.0122	CcSEcCtD
Thiamine—Hypersensitivity—Imiquimod—skin cancer	0.00307	0.0116	CcSEcCtD
Thiamine—Asthenia—Imiquimod—skin cancer	0.00299	0.0113	CcSEcCtD
Thiamine—Anaphylactic shock—Bleomycin—skin cancer	0.00296	0.0112	CcSEcCtD
Thiamine—Pruritus—Imiquimod—skin cancer	0.00295	0.0111	CcSEcCtD
Thiamine—Nausea—Vemurafenib—skin cancer	0.0029	0.011	CcSEcCtD
Thiamine—SLC22A5—female reproductive system—skin cancer	0.00284	0.0181	CbGeAlD
Thiamine—Agitation—Temozolomide—skin cancer	0.00281	0.0106	CcSEcCtD
Thiamine—Angioedema—Temozolomide—skin cancer	0.00279	0.0106	CcSEcCtD
Thiamine—Anaphylactic shock—Temozolomide—skin cancer	0.0025	0.00944	CcSEcCtD
Thiamine—Nausea—Imiquimod—skin cancer	0.00247	0.00936	CcSEcCtD
Thiamine—Hyperhidrosis—Temozolomide—skin cancer	0.00241	0.00913	CcSEcCtD
Thiamine—Urticaria—Bleomycin—skin cancer	0.00235	0.00889	CcSEcCtD
Thiamine—Haemoglobin—Docetaxel—skin cancer	0.00235	0.00888	CcSEcCtD
Thiamine—Haemorrhage—Docetaxel—skin cancer	0.00234	0.00884	CcSEcCtD
Thiamine—Anaphylactic shock—Fluorouracil—skin cancer	0.0023	0.0087	CcSEcCtD
Thiamine—Hypersensitivity—Bleomycin—skin cancer	0.00218	0.00824	CcSEcCtD
Thiamine—Asthenia—Bleomycin—skin cancer	0.00212	0.00803	CcSEcCtD
Thiamine—Pruritus—Bleomycin—skin cancer	0.00209	0.00792	CcSEcCtD
Thiamine—Hypersensitivity—Dactinomycin—skin cancer	0.00203	0.00769	CcSEcCtD
Thiamine—Urticaria—Temozolomide—skin cancer	0.00198	0.0075	CcSEcCtD
Thiamine—Asthenia—Dactinomycin—skin cancer	0.00198	0.00749	CcSEcCtD
Thiamine—Hypersensitivity—Temozolomide—skin cancer	0.00184	0.00695	CcSEcCtD
Thiamine—Urticaria—Fluorouracil—skin cancer	0.00183	0.00691	CcSEcCtD
Thiamine—Asthenia—Temozolomide—skin cancer	0.00179	0.00677	CcSEcCtD
Thiamine—Pruritus—Temozolomide—skin cancer	0.00177	0.00668	CcSEcCtD
Thiamine—Nausea—Bleomycin—skin cancer	0.00176	0.00665	CcSEcCtD
Thiamine—Hypersensitivity—Fluorouracil—skin cancer	0.00169	0.00641	CcSEcCtD
Thiamine—Anaphylactic shock—Docetaxel—skin cancer	0.00166	0.00628	CcSEcCtD
Thiamine—SLC22A5—lymph node—skin cancer	0.00166	0.0106	CbGeAlD
Thiamine—Nausea—Dactinomycin—skin cancer	0.00164	0.0062	CcSEcCtD
Thiamine—Shock—Docetaxel—skin cancer	0.00163	0.00618	CcSEcCtD
Thiamine—Pruritus—Fluorouracil—skin cancer	0.00163	0.00615	CcSEcCtD
Thiamine—Nausea—Temozolomide—skin cancer	0.00148	0.00561	CcSEcCtD
Thiamine—Nausea—Fluorouracil—skin cancer	0.00137	0.00517	CcSEcCtD
Thiamine—Hypersensitivity—Docetaxel—skin cancer	0.00122	0.00463	CcSEcCtD
Thiamine—Asthenia—Docetaxel—skin cancer	0.00119	0.0045	CcSEcCtD
Thiamine—Pruritus—Docetaxel—skin cancer	0.00117	0.00444	CcSEcCtD
Thiamine—Nausea—Docetaxel—skin cancer	0.000986	0.00373	CcSEcCtD
